163 related articles for article (PubMed ID: 10408356)
1. Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells.
Ouar Z; Lacave R; Bens M; Vandewalle A
Cell Biol Toxicol; 1999 Apr; 15(2):91-100. PubMed ID: 10408356
[TBL] [Abstract][Full Text] [Related]
2. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Hoffman MM; Wei LY; Roepe PD
J Gen Physiol; 1996 Oct; 108(4):295-313. PubMed ID: 8894978
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
5. Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
Larsen AK; Escargueil AE; Skladanowski A
Pharmacol Ther; 2000 Mar; 85(3):217-29. PubMed ID: 10739876
[TBL] [Abstract][Full Text] [Related]
6. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
Altenberg GA; Young G; Horton JK; Glass D; Belli JA; Reuss L
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9735-8. PubMed ID: 8105483
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
9. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
10. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
11. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
12. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
Roepe PD; Wei LY; Cruz J; Carlson D
Biochemistry; 1993 Oct; 32(41):11042-56. PubMed ID: 8105888
[TBL] [Abstract][Full Text] [Related]
13. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance transporters and modulation.
Tan B; Piwnica-Worms D; Ratner L
Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
[TBL] [Abstract][Full Text] [Related]
15. Visualization of multidrug resistance in vivo.
Hendrikse NH; Franssen EJ; van der Graaf WT; Vaalburg W; de Vries EG
Eur J Nucl Med; 1999 Mar; 26(3):283-93. PubMed ID: 10079321
[TBL] [Abstract][Full Text] [Related]
16. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
[TBL] [Abstract][Full Text] [Related]
18. Biophysical aspects of P-glycoprotein-mediated multidrug resistance.
Wadkins RM; Roepe PD
Int Rev Cytol; 1997; 171():121-65. PubMed ID: 9066127
[TBL] [Abstract][Full Text] [Related]
19. pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs.
Raghunand N; Martínez-Zaguilán R; Wright SH; Gillies RJ
Biochem Pharmacol; 1999 May; 57(9):1047-58. PubMed ID: 10796075
[TBL] [Abstract][Full Text] [Related]
20. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
